Controlling severe side effects of anti-cancer therapies
Ondansetron Kabi belongs to the class of 5-HT3 (Hydroxytryptamine 3) receptor antagonists. Ondansetron Kabi effectively controls nausea and vomiting associated with chemo- and radiotherapy as well as in post-operative patients.
Ondansetron injection is indicated for the management of nausea and vomiting induced by cytotoxic therapy and radiotherapy. Ondansetron injection is also indicated for the prevention and treatment of post-operative nausea and vomiting.
| Strengths | Packaging | Pack size* |
|---|---|---|
| 4 mg/2 ml | 2 ml clear glass ampoules | 1, 5 or 10 |
| 8 mg/4 ml | 4 ml clear glass ampoules | 1, 5 or 10 |
* Not all pack sizes may be marketed or available locally.
* Product images are for illustration purposes only.
Please note that this product may not be available in all countries due to different registration status. Additionally, approved indications, contraindications, side effects, warnings and all other product characteristics may differ between countries.
If you require any information, please contact your local organization.
